FDA approves new treatment for Type 2 diabetes

Posted by (author unknown) on Monday May 2, 2011 Under Uncategorized

The U.S. Food and Drug Administration today approved Tradjenta (linagliptin) tablets, used with diet and exercise, to improve blood glucose control in adults with Type 2 diabetes.

Be Sociable, Share!

Comments are closed.